Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.
3.

Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.

Sidhu AB, Uhlemann AC, Valderramos SG, Valderramos JC, Krishna S, Fidock DA.

J Infect Dis. 2006 Aug 15;194(4):528-35. Epub 2006 Jul 11.

4.

Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.

Price RN, Uhlemann AC, van Vugt M, Brockman A, Hutagalung R, Nair S, Nash D, Singhasivanon P, Anderson TJ, Krishna S, White NJ, Nosten F.

Clin Infect Dis. 2006 Jun 1;42(11):1570-7. Epub 2006 Apr 26.

5.

Role of pfmdr1 mutations on chloroquine resistance in Plasmodium falciparum isolates with pfcrt K76T from Papua New Guinea.

Mita T, Kaneko A, Hombhanje F, Hwaihwanje I, Takahashi N, Osawa H, Tsukahara T, Masta A, Lum JK, Kobayakawa T, Ishizaki T, Björkman A.

Acta Trop. 2006 May;98(2):137-44. Epub 2006 Apr 18.

PMID:
16620743
6.

Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6.

Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O.

Lancet. 2005 Dec 3;366(9501):1960-3.

PMID:
16325698
7.

Antimalarial drug resistance in Africa: strategies for monitoring and deterrence.

Plowe CV.

Curr Top Microbiol Immunol. 2005;295:55-79. Review.

PMID:
16265887
8.
9.

Drug resistance hampers our capacity to roll back malaria.

Olliaro P.

Clin Infect Dis. 2005 Aug 15;41 Suppl 4:S247-57. Review.

PMID:
16032560
10.

Contribution of the pfmdr1 gene to antimalarial drug-resistance.

Duraisingh MT, Cowman AF.

Acta Trop. 2005 Jun;94(3):181-90. Review.

PMID:
15876420
11.

SNP discovery in associating genetic variation with human disease phenotypes.

Suh Y, Vijg J.

Mutat Res. 2005 Jun 3;573(1-2):41-53. Review.

PMID:
15829236
13.

The potential role of genes in nonalcoholic fatty liver disease.

Day CP.

Clin Liver Dis. 2004 Aug;8(3):673-91, xi. Review.

PMID:
15331069
14.

Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi.

Mita T, Kaneko A, Lum JK, Bwijo B, Takechi M, Zungu IL, Tsukahara T, Tanabe K, Kobayakawa T, Björkman A.

Am J Trop Med Hyg. 2003 Apr;68(4):413-5.

PMID:
12875289
15.

Critical comparison of molecular genotyping methods for detection of drug-resistant Plasmodium falciparum.

Ranford-Cartwright LC, Johnston KL, Abdel-Muhsin AM, Khan BK, Babiker HA.

Trans R Soc Trop Med Hyg. 2002 Sep-Oct;96(5):568-72.

PMID:
12474492
16.

Genotyping of Plasmodium falciparum. PCR-RFLP analysis.

Felger I, Beck HP.

Methods Mol Med. 2002;72:117-29. No abstract available.

PMID:
12125107
17.

Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria.

Djimdé A, Doumbo OK, Steketee RW, Plowe CV.

Lancet. 2001 Sep 15;358(9285):890-1. No abstract available.

PMID:
11567708
18.

A molecular marker for chloroquine-resistant falciparum malaria.

Djimdé A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourté Y, Coulibaly D, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV.

N Engl J Med. 2001 Jan 25;344(4):257-63.

19.

Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.

Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF.

Nature. 2000 Feb 24;403(6772):906-9.

PMID:
10706290
20.

Making malaria-treatment policy in the face of drug resistance.

Bloland PB, Ettling M.

Ann Trop Med Parasitol. 1999 Jan;93(1):5-23. Review.

PMID:
10492667

Supplemental Content

Support Center